Baldapan, Joana .
HRN: 23-58-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/12/2023
09/19/2023
IV
30mg
Q8hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes